According to human studies, insulin and insulin-like growth factor (IGF) signaling are significantly disrupted in AD, which supports the hypothesis that AD is a brain-specific form of "type 3 diabetes” [6]. This evidence concerns the gene IGF1 and Alzheimer disease.